Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析

◆英語タイトル:Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8010016
◆発行会社(調査会社):GlobalData
◆発行日:2018年1月11日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:小売
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Australian Pharmaceutical Industries Ltd (API) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Australian Pharmaceutical Industries Ltd (API) is an integrated healthcare services company that primarily produces, retails, markets and sells health and beauty care products. It markets these products under various brands such as Priceline & Priceline Pharmacy, Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys. API procures various health, beauty, and lifestyle products and sells them on retail basis. It also manufactures pharmaceutical products; and owns rights of medicines and consumer toiletries in New Zealand. A part from these, it offers pharmacy services, professional care services and counselling for various patients related to specific medication needs. API is headquartered in Camberwell, Victoria, Australia.

Australian Pharmaceutical Industries Ltd Key Recent Developments

Apr 20,2017: Australian Pharmaceutical Industries posts 27% rise in H1 profit

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Australian Pharmaceutical Industries Ltd – Key Facts 5
Australian Pharmaceutical Industries Ltd – Key Employees 6
Australian Pharmaceutical Industries Ltd – Key Employee Biographies 7
Australian Pharmaceutical Industries Ltd – Major Products and Services 8
Australian Pharmaceutical Industries Ltd – History 9
Australian Pharmaceutical Industries Ltd – Company Statement 10
Australian Pharmaceutical Industries Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
Australian Pharmaceutical Industries Ltd – Business Description 15
Australian Pharmaceutical Industries Ltd – SWOT Analysis 16
SWOT Analysis – Overview 16
Australian Pharmaceutical Industries Ltd – Strengths 16
Australian Pharmaceutical Industries Ltd – Weaknesses 17
Australian Pharmaceutical Industries Ltd – Opportunities 18
Australian Pharmaceutical Industries Ltd – Threats 19
Australian Pharmaceutical Industries Ltd – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Australian Pharmaceutical Industries Ltd, Key Facts 5
Australian Pharmaceutical Industries Ltd, Key Employees 6
Australian Pharmaceutical Industries Ltd, Key Employee Biographies 7
Australian Pharmaceutical Industries Ltd, Major Products and Services 8
Australian Pharmaceutical Industries Ltd, History 9
Australian Pharmaceutical Industries Ltd, Other Locations 13
Australian Pharmaceutical Industries Ltd, Subsidiaries 13
Australian Pharmaceutical Industries Ltd, Key Competitors 20
Australian Pharmaceutical Industries Ltd, Ratios based on current share price 21
Australian Pharmaceutical Industries Ltd, Annual Ratios 22
Australian Pharmaceutical Industries Ltd, Annual Ratios (Cont...1) 23
Australian Pharmaceutical Industries Ltd, Annual Ratios (Cont...2) 24
Australian Pharmaceutical Industries Ltd, Interim Ratios 26
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

★海外企業調査レポート[Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Universal Forest Products, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Universal Forest Products, Inc. …
  • Usha Martin Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Usha Martin Limited Mergers and …
  • Gemini Corp (GKX)-石油・ガス分野:企業M&A・提携分析
    Summary Gemini Corporation (Gemini) is an oil and gas engineering company that provides engineering, field and environmental solutions. The company offers services including project management systems, fabrication, maintenance, procurement, construction, land, environmental, regulatory, and reclamat …
  • China Communications Services Corporation Limited (552):企業概要、財務及び戦略的SWOT分析
    Summary China Communications Services Corporation Limited (CCSCL) is a provider of telecommunication support services. The company provides telecommunications infrastructure services, business process outsourcing services, and applications, content and other services. CCSCL's telecommunication infra …
  • Xcellerex, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Xcellerex, Inc. Mergers and Acq …
  • Chaucer Holdings PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Chaucer Holdings PLC Mergers an …
  • DENSO Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DENSO Corporation Mergers and A …
  • Mediclinic International Plc (MDC):企業財務及び戦略的SWOT分析
    Summary Mediclinic International Plc(Mediclinic), formerly Al Noor Hospitals Group Plc is a healthcare provider that offers acute care, specialist-orientated and multi-disciplinary healthcare services. The center offers healthcare services in the therapeutic areas such as rheumatology, immunology, m …
  • NorCom Information Technology AG (NC5A):企業財務及び戦略的SWOT分析
    Summary NorCom Information Technology AG (NorCom) is a technology and consulting company that offers IT consulting and software solutions. The company provides software such as NCPower, NCSignage and Eagle. It offers business and IT-consulting services. NorCom’s business media consulting supports wi …
  • Baker & McKenzie LLP:企業の戦略的SWOT分析
    Baker & McKenzie LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ConceptoMed AS:企業のM&A・提携動向(医療機器分野)
    Summary ConceptoMed AS (ConceptoMed) is a medical device manufacturer that develops and commercializes medical devices for the healthcare market. Its products include medical syringe and needle, medical tools, Luer-Jack, ConceptoShield, and disposable medical instruments and devices. ConceptoMed als …
  • King’s College London:企業のM&A・提携動向(医療機器分野)
    Summary King's College London (KCL), a part of University of London is a research and educational institution. It offers undergraduate, postgraduate, internship programs, summer school, executive education and short courses. The institution provides courses across various disciplines including arts …
  • Asahi Kasei Corp (3407):企業のM&A・提携動向(医療機器分野)
    Summary Asahi Kasei Corp (Asahi Kasei), formerly known as Asahi Chemical Industry Co. Ltd., is a holding company of Asahi Kasei Group. The company’s product portfolio includes polymers, acrylonitrile, caustic soda, styrene, diagnostic reagents, nutritional products, contact lenses, medical devices a …
  • Advanced Logistics Development (ALD):企業財務及び戦略的SWOT分析
    Summary Advanced Logistics Development (ALD) is a software consulting firm that offers professional consulting, software development, and training services. The firm provides software products such as RAM commander, FavoWeb, D-LCC, SPC, FacoScope and ALDCollege course management software system. Its …
  • Aduro BioTech Inc (ADRO):企業のM&A・提携動向(医療分野)
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that focuses on the discovery, development and commercialization of therapies for the treatment of cancer. The company develops its product candidates using its proprietary technology platforms such as live, attenuat …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務分析
    SummaryAselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view o …
  • Uniphos Enterprises Limited (UNIENTER):企業概要、財務及び戦略的SWOT分析
    Summary Uniphos Enterprises Limited (Uniphos Enterprises) is a chemical trading company. The company trades and markets various chemical products for different applications. It offers product such as chemicals and other chemical related products. It markets its products in India and overseas chemica …
  • Petroleos Mexicanos:企業のM&A・提携動向(発電分野)
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. It is one of the leading energy companies across the South America. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers …
  • Ashmore Group plc:企業の戦略・SWOT・財務分析
    SummaryAshmore Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Suda Ltd (SUD):企業の財務及び戦略的SWOT分析
    Summary Suda Ltd (Suda) is a drug delivery company that develops and markets oro-mucosal drug delivery technology for development of pharmaceuticals. The company offers products such as artimist, zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its artimist is a sub-lingual spray for the t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆